Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chicago, Illinois
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- N/A
- Filings on record
- 346 filings
- On EDGAR
- CIK 1867096
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 21
News 8 of 58
Prospectuses and Registrations 8 of 15
- S-8 Registration statement for an employee plan Mar 2, 2026
- S-8 Registration statement for an employee plan Mar 6, 2025
- S-3 Shelf registration statement Mar 6, 2025
- S-8 Registration statement for an employee plan Aug 8, 2024
- S-8 Registration statement for an employee plan Mar 6, 2024
- S-8 Registration statement for an employee plan Mar 8, 2023
- 424B5 Prospectus supplement for an offering May 11, 2022
- S-8 Registration statement for an employee plan Mar 11, 2022
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEFA14A Extra proxy material Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
Ownership 8 of 217
- 4 Insider reported a trade Nov 6, 2026
- 144 Notice of a proposed sale of restricted stock Nov 5, 2026
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 3 Insider reported their initial holding Nov 4, 2026
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
Other 8 of 24
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective May 13, 2025
- CORRESP Reply to SEC staff May 9, 2025
- ARS Annual report sent to shareholders Apr 23, 2025
- UPLOAD Comment letter from SEC staff Mar 11, 2025
- UPLOAD Comment letter from SEC staff Aug 13, 2024
- CORRESP Reply to SEC staff Aug 6, 2024
- UPLOAD Comment letter from SEC staff Jul 22, 2024
Everything here comes from Xeris Biopharma Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.